Back to Epidermolysis Bullosa

Research record changes

The latest 100 trial status and retraction changes detected since change tracking began. Dates show when RareWays recorded the change, which may be later than the source update. Earlier history is unavailable.

  1. A 44-week Monocentric Open Study Assessing the Efficacy and Safety of Deucravacitinib in Adults With Inflammatory Genodermatoses

    RECRUITING → COMPLETED

    Recorded 2026-10-16

    View record
  2. Study to Evaluate Safety and Efficacy of ALLO-ASC-SHEET in Subjects With Dystrophic Epidermolysis Bullosa

    RECRUITING → UNKNOWN

    Recorded 2026-10-01

    View record
  3. Study of the Blood and Skin Immunological Profile of Patients With Recessive Dystrophic Epidermolysis Bullosa: in Vivo Analysis and the Impact of Placental Stem Cells in Vitro

    RECRUITING → UNKNOWN

    Recorded 2026-10-01

    View record